Testicular Cancer

• Home
• What is Testicular Cancer?
• Am I at Risk?
• Screening Guidelines
• Testicular Self Exam (TSE)
• Seek Medical Advice
• Diagnosis
• Imaging and Staging
• Treatment Options
• Prognosis and Statistics
• Follow up care
• Short Term Complications
• Long Term Considerations
• Community Resources
• Live Forum
• References

References

Albers, P., Albrecht W., Algaba, F., Bokemeyer, C., Cohn-Cedermark, G., Horwich, A., et al. (2008). Guidelines on testicular cancer. Retrieved from www.guidelines.gov on November 11, 2008.

American Cancer Society. (2008). Detailed Guide: Testicular Cancer. Cancer Reference Center. Retrieved on November 11, 2008 from:
http://www.cancer.org/docroot/lrn/lrn_0.asp

Gilligan, T. (2007). Testis cancer: rare, but curable with prompt referral. Cleveland Clinic Journal of Medicine, 74(11): 817-825. 

Heidenreich, A. & Hofmann, R. (1999). Quality-of-life issues in the treatment of testicular cancer. World Journal of Urology, 17(4): 230-238.

Huddard, R.A., Norman, A., Moynihan, C. (2005). Fertility, gonadal, and sexual function in survivors of testicular cancer. British Journal of Cancer, 93(2): 200-207.

Kaufman, M.R. & Chang, S.S. (2007). Short- and long-term complications of therapy for testicular cancer. Urologic Clinics of North America, 34(22): 259-268.

Kollmannsbergy, C., Kuzcyk, M., Mayer, F., Hartmann, J., Kanzy L., & Bokemyer, C. (1999). Late toxicity following curative treatment of testicular cancer. Seminars in Surgical Oncology, 17: 275-281.

National Cancer Institute. (2008). Testicular Cancer Treatment (PDQ).  Retrieved on October 23, 2008 from: http://www.cancer.gov/cancertopics/types/testicular/.

Oh, J.H., Baum, D.D., Pham, S., Cox, M., Nguyen, S.T., Ensor, J., & Chen, I. (2007). Long-term complications of platinum-based chemotherapy in testicular cancer survivors. Medical Oncology, 24(2): 175-181.

Petersen, P.M., Giwercman, A., Skakkebaek, N.E., & Rorth, M. (1998) Gonadal function in men with testicular cancer. Seminars in Oncology, 25: 224–233. 

Screening for Testicular Cancer, Topic Page. February 2004. U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/uspstf/uspstest.htm.

Stephenson, A.J., Kuritzky, L., & Campbell, S.C. (2007). Screening for urologic malignancies in primary care: the pros, cons, and recommendations. Cleveland Clinic Journal of Medicine, 74(3): 6-14.

Van Den Belt-Dusebout, A., De Wit, R., Gietema, J., Horenblas, S., Louwman, M., Ribot, J., et al.(2007). Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25: 4370-4378.

Vaughn, D., Palmer, S., Carver, J., Jacobs, L., & Mohler, E. (2008). Cardiovascular risk in long-term survivors of testicular cancer. Cancer, 112: 1949-1953.


Ziebland , S., Chapple , A., Dumelow , C., Evans , Prinjha , S., & Rozmovits , L. (2004). How the internet affects patients' experience with cancer: A qualitative study. The British Medical Journal, 328 (7439): 564-567.